BQ-123 is a cyclic pentapeptide that functions as a potent and selective endothelin A (ETA) receptor antagonist, primarily utilized in scientific research to modulate endothelin-1 signaling pathways, including… Read more
BQ-123 is a cyclic pentapeptide that functions as a potent and selective endothelin A (ETA) receptor antagonist, primarily utilized in scientific research to modulate endothelin-1 signaling pathways, including those involved in vasoconstriction, cell proliferation, and renal physiology. Pharmaceutical laboratories rely on this category of high-quality reference standards to support rigorous analytical method development and quality control protocols. The inclusion of stable isotope labelled compounds, such as deuterated and 13C/15N-labelled variants, provides researchers with essential internal standards for the precise quantification of the parent drug in complex biological matrices via LC-MS/MS. Furthermore, these reference materials are critical for impurity profiling and the identification of degradation products, ensuring the high level of accuracy required in pharmaceutical synthesis and stability testing. By providing standardized chemical references, these products enable consistent and reliable data in the ongoing investigation of the endothelin system.